Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Clarke

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Journal of Human Hypertension|July 17, 1999
Does the treatment of isolated systolic hypertension prevent dementia?C E Clarke
Hospital Medicine (London, England : 1998)|February 8, 2003
Dopamine agonist monotherapy in early Parkinson's diseaseC E Clarke
European Journal of Neurology|November 29, 2013
Botulinum toxin type A in cerebellar tremor caused by multiple sclerosisC E Clarke
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1993
Mortality from Parkinson's disease in England and Wales 1921-89C E Clarke
Journal of Neurology, Neurosurgery, and Psychiatry|March 4, 2000
Mortality from Parkinson's diseaseC E CLarke
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2004
Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's diseaseC E Clarke
BMJ (Clinical Research Ed.)|September 1, 2007
Parkinson's diseaseC E Clarke
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 2002
Medical management of Parkinson's diseaseC E Clarke
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Does levodopa therapy delay death in Parkinson's disease? A review of the evidenceC E Clarke
Journal of Neurology|November 17, 2010
Has drug therapy changed the natural history of Parkinson's disease?C E Clarke
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Human Hypertension|July 17, 1999
Does the treatment of isolated systolic hypertension prevent dementia?C E Clarke
Hospital Medicine (London, England : 1998)|February 8, 2003
Dopamine agonist monotherapy in early Parkinson's diseaseC E Clarke
European Journal of Neurology|November 29, 2013
Botulinum toxin type A in cerebellar tremor caused by multiple sclerosisC E Clarke
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1993
Mortality from Parkinson's disease in England and Wales 1921-89C E Clarke
Journal of Neurology, Neurosurgery, and Psychiatry|March 4, 2000
Mortality from Parkinson's diseaseC E CLarke
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2004
Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's diseaseC E Clarke
BMJ (Clinical Research Ed.)|September 1, 2007
Parkinson's diseaseC E Clarke
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 2002
Medical management of Parkinson's diseaseC E Clarke
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Does levodopa therapy delay death in Parkinson's disease? A review of the evidenceC E Clarke
Journal of Neurology|November 17, 2010
Has drug therapy changed the natural history of Parkinson's disease?C E Clarke
Pageof 11